These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15155136)

  • 1. Emerging treatments in acute myeloid leukaemia.
    Kell J
    Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesyltransferase inhibitor therapy in acute myelogenous leukemia.
    Gotlib J
    Curr Hematol Rep; 2005 Jan; 4(1):77-84. PubMed ID: 15610664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
    Mandelli F; Petti MC; Lo Coco F
    Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
    Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current therapeutic strategies for acute myeloid leukaemia.
    Kolitz JE
    Br J Haematol; 2006 Sep; 134(6):555-72. PubMed ID: 16848792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New agents in the treatment of acute myeloid leukemia: a snapshot of signal transduction modulation.
    Bao T; Smith BD; Karp JE
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):287-96, 302. PubMed ID: 16167001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
    Ferrara F
    Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia.
    Morgan MA; Ganser A; Reuter CW
    Leukemia; 2003 Aug; 17(8):1482-98. PubMed ID: 12886235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel agents in acute myeloid leukemia.
    Aribi A; Ravandi F; Giles F
    Cancer J; 2006; 12(2):77-91. PubMed ID: 16630396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New agents for the treatment of acute myeloid leukemia.
    Tallman MS
    Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
    Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
    Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics therapy in AML.
    Radich GP
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):11-4. PubMed ID: 19645131
    [No Abstract]   [Full Text] [Related]  

  • 16. FLT3 Inhibitors in the Treatment of AML.
    Gilliland DG
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):708-10. PubMed ID: 16163256
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of acute myeloid leukemia in older patients.
    Roboz GJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):285-95. PubMed ID: 17338649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for head and neck cancer.
    Rhee JC; Khuri FR; Shin DM
    Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting epigenetic changes in acute myeloid leukemia.
    Blum W; Marcucci G
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):855-65, 882. PubMed ID: 16491631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesyltransferase inhibitors as anticancer agents: critical crossroads.
    Doll RJ; Kirschmeier P; Bishop WR
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):478-86. PubMed ID: 15338957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.